May 22nd 2025, 9:00pm
Among patients with ES-SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.
May 22nd 2025, 7:00pm
Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer.
May 22nd 2025, 5:00pm
When I saw a study about using AI facial recognition in cancer decision-making headlines, I decided to try my own informal, non-scientific experiment.
May 22nd 2025, 4:29pm
The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate cancer, respectively.
May 22nd 2025, 3:00pm
A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB-102 trial.
May 22nd 2025, 1:00pm
DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin, suggesting preserved cochlear function.
May 21st 2025, 9:00pm
Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, is a trailblazer whose expertise and compassion have made a profound impact on oncology care.
May 21st 2025, 8:18pm
JAK inhibitors ease symptoms in myelofibrosis, but only stem cell transplant offers a cure; newer drugs aim to fill unmet needs, especially for anemia.
May 21st 2025, 7:00pm
Dr. Shirley D’Sa discusses how treatment strategies for WM have evolved over the course of her career.
May 21st 2025, 5:00pm
I'm a follicular lymphoma survivor, and hearing others name the quiet, lasting changes of life after cancer made me feel seen and understood.
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis
Experts Discuss New Advances in Bladder Cancer Following ESMO 2025
What I Learned About Previvorship and Representation in Social Media